title: Hypertrophic cardiomyopathy: role of current recommendations by the american heart association for infective endocarditis.
abstract: In the past decade, there has been evolution in the diagnosis, management, and long-term care of patients with infective endocarditis and its complications. This includes the relatively new but contentious prophylactic antibiotic regimen. However, these cases still continue to pose a challenge in the adult and pediatric populations. We present a case of a teenager with hypertrophic cardiomyopathy that had an atypical presentation of infective endocarditis.
authors.affiliation: John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.
authors.forename: Natasha
authors.initials: N
authors.lastname: Noel
authors.forename: Zahra
authors.initials: Z
authors.lastname: Naheed
mesh_terms: D000293:Adolescent; D000572:American Heart Association; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications* / Q000000981:diagnostic imaging / Q000503:physiopathology; D004359:Drug Therapy, Combination; D015150:Echocardiography, Doppler / Q000379:methods; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D010406:Penicillins / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D013290:Streptococcal Infections / Q000175:diagnosis / Q000188:drug therapy*; D054773:Streptococcus gordonii / Q000302:isolation & purification*; D016896:Treatment Outcome; D014481:United States
chemical_list: D005839:Gentamicins; D010406:Penicillins